Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine fumarate for Williams syndrome (randomized crossover, placebo-controlled, phase 2)
ChiCTR2500105345Phase 2Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of clemastine in Williams syndrome (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Fractional anisotropy, Social cognition score and 1 more. Started Jul 2025; status: completed.
02
Drugs
clemastine
03
Conditions
Williams syndrome
Beyond the preview
Go deeper on ChiCTR2500105345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105345.